Alzheimer-Erkrankung
Die Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.
- Rauchen
- Rauchen
- Geschlecht
- Mann oder Frau
- Alter
- 18-55 jaar
Clinical trial of a new compound that is being developed for the treatment of heart failure.
Note:
As a female you can only participate if you meet one of the following conditions:
As a male you can only participate if you meet one of the following conditions;
The trial consists of 4 parts: part A, part B, part C and part D. You can only participate in one part of this clinical trial.
Part A consists of 1 period during which you will stay in the research facility in Groningen (location van Swietenlaan 6) for 7 days (6 nights). The follow-up visit will take place on the day of your departure from the research facility. 21 to 27 days (about 4 weeks) after your departure from the research facility, you will be contacted by phone for some questions.
Note: You must be available for all dates to be able to participate in this clinical trial.
Group B5a | |
period of stay |
|
follow-up |
|
follow-up | Follow up appointment on 14th or 15th of August |
Group B5b | |
period of stay |
|
follow-up |
|
follow-up | Follow up appointment on 20th of 21th augustus |
For participation in one of the groups of part B of the trial, you will receive a gross compensation of €3199.
Travelling expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per round trip, regardless of the mode of transportation.